Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for ...

IV robotics and workflow preparation technology is critical to the advancement of patient safety and accuracy in IV compounding. But while the need is widely recognized, barriers to adoption – ...

Vyvo Therapeutics has announced the launch of its IV therapy service, now available at its medical spa located at 2817 W Loop ...

Celltrion announced that the European Commission (EC) has granted marketing authorization for Remsima IV (intravenous) liquid ...

Ensuring clinically sound, cost-effective medication therapy is a critical function of pharmacists. Yet addressing the costly and potentially dangerous process of sterile IV compounding—one of the ...

King of Prussia, PA - The FDA has approved a novel formulation of amiodarone hydrochloride for intravenous (IV) use (Nexterone injection) that doesn't include polysorbate 80 or benzyl alcohol, ...

Adjunct Assistant Professor, Department of Psychiatry, Division of Child and Adolescent Psychiatry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada A ...

Smith & Nephew has announced a voluntary nationwide recall of selected lots of IV PREP Antiseptic Wipes, manufactured for Smith & Nephew by The Triad Group, according to a company news release. Smith ...